BE0387-50MG
| InVivoMAb anti-mouse/human phosphorylated PD-1 (CD279)
| 50 mg
| BioXCell
| Western Blot, Flow Cytometry
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BP0273-100MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0146-100MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0033-2-50MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BE0387-1MG
| InVivoMAb anti-mouse/human phosphorylated PD-1 (CD279)
| 1 mg
| BioXCell
| Western Blot, Flow Cytometry
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BE0387-100MG
| InVivoMAb anti-mouse/human phosphorylated PD-1 (CD279)
| 100 mg
| BioXCell
| Western Blot, Flow Cytometry
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
BP0033-2-100MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
BP0146-50MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
BP0033-2-5MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
CP151-1MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP155-1MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP153-25MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
SIM0003-25MG
| InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
| 25 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Flow Cytometry, I
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
CP162-50MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP162-100MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP002-1MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP162-1MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
SIM0010-1MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 1 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
SIM0010-100MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 100 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
CP159-25MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*
, in vitr
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
CP004-1MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP005-1MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*
, in vitr
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP153-5MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP151-5MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP157-5MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP151-100MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP159-100MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*
, in vitr
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
CP157-1MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
SIM0003-100MG
| InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
| 100 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Flow Cytometry, I
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
CP157-25MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP153-1MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP159-50MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*
, in vitr
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
CP153-50MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP159-1MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*
, in vitr
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
CP155-5MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP162-5MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
SIM0010-25MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 25 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
SIM0003-50MG
| InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
| 50 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Flow Cytometry, I
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
CP162-25MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP151-25MG
| RecombiMAb anti-mouse PD-1 (CD279) (D265A)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP157-100MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP159-5MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 5 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*
, in vitr
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
CP157-50MG
| RecombiMAb anti-mouse PD-1 (CD279)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP155-50MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 50 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
SIM0003-1MG
| InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
| 1 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Flow Cytometry, I
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
CP155-25MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP153-100MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, *Reporte
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
CP155-100MG
| RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG)
| 100 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling*, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
SIM0010-50MG
| InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar)
| 50 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Functional assays
|
| Human
| Human
| Solicitar Precio
| Solicitar
|
SIM0003-5MG
| InVivoSIM anti-human PD-1 (Nivolumab Biosimilar)
| 5 mg
| BioXCell
| Blocking of PD-1/PD-L signaling, Flow Cytometry, I
|
| Human
| Human
| Solicitar Precio
| Solicitar
|